Reported Earlier, Silexion Therapeutics Announces Immediate Exercise Of Warrants For $1.8M In Gross Proceeds And Issues New Unregistered Warrants

Author: Benzinga Newsdesk | August 01, 2025 02:16am

In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered warrants to purchase up to 304,212 of the Company's ordinary shares. The new warrants will have an exercise price of $11.32 per share, will be exercisable upon the effective date of the increase of the Company's authorized ordinary shares following shareholder approval and will have a term of twenty-four months from the effective date of the Resale Registration Statement (as defined below).

Posted In: SLXN